A Randomized, Double-blind, Placebo-controlled Study of an Acetylcholinesterase Inhibitor in the Management of Delirium in Hospitalized Patients Aged 75 Years and Over

Trial Profile

A Randomized, Double-blind, Placebo-controlled Study of an Acetylcholinesterase Inhibitor in the Management of Delirium in Hospitalized Patients Aged 75 Years and Over

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jul 2016

At a glance

  • Drugs Rivastigmine (Primary)
  • Indications Delirium; Dementia
  • Focus Therapeutic Use
  • Acronyms CONFU-RIV
  • Most Recent Events

    • 19 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 22 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 12 Nov 2014 Planned End Date changed from 1 Jun 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top